Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 384747101 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Baker Bros. Advisors LP
13G/A
|
9.8% |
5/15/2026
Event 3/31/2026
|
||
| Baker Bros. Advisors LP | 9.8% | |||
| Baker Bros. Advisors (GP) LLC | 9.8% | |||
| Julian C. Baker | 9.8% | |||
| Felix J. Baker | 9.8% | |||
|
Farallon Capital Management, L.L.C.
13G/A
|
9.6% |
8/13/2026
Event 6/30/2026
|
||
| Farallon Capital Management, L.L.C. | 9.6% | |||
| Farallon Capital Partners, L.P. | 0% | |||
| Farallon Capital Institutional Partners, L.P. | 0% | |||
| Farallon Capital Institutional Partners II, L.P. | 0% | |||
| Farallon Capital Institutional Partners III, L.P. | 0% | |||
| Four Crossings Institutional Partners V, L.P. | 0% | |||
| Farallon Capital Offshore Investors II, L.P. | 0% | |||
| Farallon Capital (AM) Investors, L.P. | 0% | |||
| Farallon Capital F5 Master I, L.P. | 0% | |||
| Farallon Healthcare Partners Master, L.P. | 0% | |||
| Farallon Partners, L.L.C. | 0% | |||
| Farallon Institutional (GP) V, L.L.C. | 0% | |||
| Farallon F5 (GP), L.L.C. | 0% | |||
| Farallon Healthcare Partners (GP), L.L.C. | 0% | |||
| Dapice Joshua J. | 9.6% | |||
| Dreyfuss, Philip D. | 9.6% | |||
| Dunn Hannah E. | 9.6% | |||
| Gehani, Varun N. | 9.6% | |||
| Giauque, Nicolas | 9.6% | |||
| Husen, Avner A. | 9.6% | |||
| Kim, David T. | 9.6% | |||
| Linn, Michael G. | 9.6% | |||
| Luo Patrick (Cheng) | 9.6% | |||
| Roberts, Jr., Thomas G. | 9.6% | |||
| Saito Edric C. | 9.6% | |||
| Short Daniel S. | 9.6% | |||
| Spokes, Andrew J. M. | 9.6% | |||
| Warren, John R. | 9.6% | |||
| Wehrly, Mark C. | 9.6% | |||
| BlackRock, Inc. 13G/A | 7.9% |
7/28/2026
Event 6/30/2026
|
||
|
Farallon Capital Partners, L.P.
13G/A
|
7.8% |
5/11/2026
Event 3/31/2026
|
||
| Farallon Capital Partners, L.P. | 0.6% | |||
| Farallon Capital Institutional Partners, L.P. | 0.7% | |||
| Farallon Capital Institutional Partners II, L.P. | 0.2% | |||
| Farallon Capital Institutional Partners III, L.P. | 0.1% | |||
| Four Crossings Institutional Partners V, L.P. | 0.1% | |||
| Farallon Capital Offshore Investors II, L.P. | 1.5% | |||
| Farallon Capital (AM) Investors, L.P. | 0.1% | |||
| Farallon Capital F5 Master I, L.P. | 0.2% | |||
| Farallon Healthcare Partners Master, L.P. | 4.5% | |||
| Farallon Partners, L.L.C. | 7.7% | |||
| Farallon Institutional (GP) V, L.L.C. | 0.1% | |||
| Farallon F5 (GP), L.L.C. | 0.2% | |||
| Farallon Healthcare Partners (GP), L.L.C. | 4.5% | |||
| Dapice Joshua J. | 7.8% | |||
| Dreyfuss, Philip D. | 7.8% | |||
| Dunn Hannah E. | 7.8% | |||
| Gehani, Varun N. | 7.8% | |||
| Giauque, Nicolas | 7.8% | |||
| Husen, Avner A. | 7.8% | |||
| Kim, David T. | 7.8% | |||
| Linn, Michael G. | 7.8% | |||
| Luo Patrick (Cheng) | 7.8% | |||
| Roberts, Jr., Thomas G. | 7.8% | |||
| Saito Edric C. | 7.8% | |||
| Short Daniel S. | 7.8% | |||
| Spokes, Andrew J. M. | 7.8% | |||
| Warren, John R. | 7.8% | |||
| Wehrly, Mark C. | 7.8% | |||
| State Street Corp 13G | 5.6% |
8/7/2026
Event 6/30/2026
|
||
| Primecap Management Co/CA/ 13G/A | 5.1% |
8/6/2026
Event 6/30/2026
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (4) | ||||
|
CRCM LP
13G/A
|
5.0%
Checked 5% or less
|
10/6/2025
Event 10/6/2025
|
||
| CRCM LP | 5.0% | |||
| CRCM Opportunity Fund III, LP | 0.6% | |||
| CRCM Opportunity Fund IV, LP | 0.9% | |||
| CRCM Institutional Master Fund (Bvi), Ltd. | 0.9% | |||
| CRCM G SPV, LP | 2.6% | |||
| CRCM LLC | 5.0% | |||
| CRCM Opportunity GP III LLC | 0.6% | |||
| CRCM Opportunity GP IV LLC | 0.9% | |||
| Ding Chun R | 5.0% | |||
|
Sessa Capital (Master), L.P.
13G/A
|
4.3% |
5/7/2025
Event 4/30/2025
|
||
| Sessa Capital (Master), L.P. | 4.3% | |||
| Sessa Capital GP, LLC | 4.3% | |||
| Sessa Capital IM, L.P. | 4.3% | |||
| Sessa Capital IM GP, LLC | 4.3% | |||
| John Petry | 4.3% | |||
| Illumina, Inc. 13G/A | 3.2% |
2/17/2026
Event 12/31/2025
|
||
| Vanguard Group Inc 13G/A | 0% |
3/27/2026
Event 3/13/2026
|
||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 55 | 389 k | $54.4 M |
| 2026 Q2 | 400 | 43.1 M | $2.79 B |
| 2026 Q1 | 389 | 35.2 M | $1.82 B |
| 2025 Q4 | 452 | 30.1 M | $2.57 B |
| 2025 Q3 | 374 | 25.0 M | $1.48 B |
| 2025 Q2 | 372 | 26.5 M | $1.36 B |
| 2025 Q1 | 334 | 24.1 M | $614 M |
| 2024 Q4 | 345 | 26.7 M | $477 M |
| 2024 Q3 | 327 | 22.1 M | $282 M |
| 2024 Q2 | 391 | 22.7 M | $349 M |
| 2024 Q1 | 2 | 135 | $2.02 k |